GLOW-70mg
Research Overview
GLOW is a three-peptide research kit containing GHK-Cu, TB-500 and BPC-157, each supplied as lyophilized powder in its own sealed sterile vial. Separate vials let investigators run single-compound and multi-compound arms within the same project and control the ratio between components.
The three compounds cover distinct research areas: extracellular matrix biology (GHK-Cu), cytoskeletal organization and cell migration (TB-500), and cytoprotection in epithelial and endothelial models (BPC-157). That combination suits multi-pathway designs that compare complementary mechanisms side by side.
For the research rationale behind this combination, see Glow Peptide Research.
Scientific Background
GHK-Cu is a copper-binding tripeptide studied for collagen, elastin and glycosaminoglycan synthesis in fibroblast models. TB-500 is a synthetic peptide derived from the actin-binding region of thymosin beta-4, investigated in cytoskeletal organization, cell migration and angiogenic signaling research. BPC-157 is a synthetic pentadecapeptide studied for cytoprotective activity across gastrointestinal and endothelial tissue models.
Multi-compound studies typically examine whether these pathways act independently or interact in tissue repair models. For the methodology behind combined BPC-157 and TB-500 research, see BPC-157 and TB-500 Research.
Molecular Information
- GHK-Cu: Copper-binding tripeptide, Gly-His-Lys with Cu(II)
- TB-500: Synthetic peptide derived from thymosin beta-4
- BPC-157: Synthetic 15 amino acid peptide
- Total content: 70mg across three vials
- Classification: Research peptide kit
Quality and Compliance
Every GENEVIUM batch is tested by independent third-party laboratories. Each component is verified separately, with reverse-phase HPLC confirming purity and mass spectrometry confirming identity, and nothing ships below 99% purity. Component-level Certificates of Analysis are available on the COA Lookup page.
